Molecular pathogenesis of mantle cell lymphoma

Por Jares, Pedro, Colomer, Dolors, Campo, Elias
Publicado em 2012

Autophagy controls everolimus (RAD001) activity in mantle cell lymphoma

Por Rosich, Laia, Colomer, Dolors, Roué, Gaël
Publicado em 2013

Enhancement of fludarabine sensitivity by all-trans-retinoic acid in chronic lymphocytic leukemia cells

Por Fernández-Calotti, Paula X., Lopez-Guerra, Mónica, Colomer, Dolors, Pastor-Anglada, Marçal
Publicado em 2012

The Expression of the Endoplasmic Reticulum Stress Sensor BiP/GRP78 Predicts Response to Chemotherapy and Determines the Efficacy of Proteasome Inhibitors in Diffuse Large B-Cell L...

Por Mozos, Ana, Roué, Gaël, López-Guillermo, Armando, Jares, Pedro, Campo, Elias, Colomer, Dolors, Martinez, Antonio
Publicado em 2011

Impact of the Functional CD5 Polymorphism A471V on the Response of Chronic Lymphocytic Leukaemia to Conventional Chemotherapy Regimens

Por Delgado, Julio, Bielig, Torsten, Bonet, Lizette, Carnero-Montoro, Elena, Puente, Xose S., Colomer, Dolors, Bosch, Elena, Campo, Elias, Lozano, Francisco
Publicado no Br J Haematol (2016)

Nuclear Survivin Expression in Mantle Cell Lymphoma Is Associated with Cell Proliferation and Survival

Por Martinez, Antonio, Bellosillo, Beatriz, Bosch, Francesc, Ferrer, Ana, Marcé, Silvia, Villamor, Neus, Ott, German, Montserrat, Emili, Campo, Elias, Colomer, Dolors
Publicado em 2004

Identification of novel tumor suppressor proteases by degradome profiling of colorectal carcinomas

Por Fraile, Julia M., Ordóñez, Gonzalo R., Quirós, Pedro M., Astudillo, Aurora, Galván, José A., Colomer, Dolors, López-Otín, Carlos, Freije, José M.P., Puente, Xose S.
Publicado em 2013

The phosphatidylinositol-3-kinase inhibitor NVP-BKM120 overcomes resistance signals derived from microenvironment by regulating the Akt/FoxO3a/Bim axis in chronic lymphocytic leuke...

Por Rosich, Laia, Saborit-Villarroya, Ifigènia, López-Guerra, Mónica, Xargay-Torrent, Sílvia, Montraveta, Arnau, Aymerich, Marta, Villamor, Neus, Campo, Elias, Pérez-Galán, Patricia, Roué, Gaël, Colomer, Dolors
Publicado em 2013

Dual PI3K/mTOR inhibition is required to effectively impair microenvironment survival signals in mantle cell lymphoma

Por Rosich, Laia, Montraveta, Arnau, Xargay-Torrent, Sílvia, López-Guerra, Mónica, Roldán, Jocabed, Aymerich, Marta, Salaverria, Itziar, Beà, Sílvia, Campo, Elías, Pérez-Galán, Patricia, Roué, Gaël, Colomer, Dolors
Publicado em 2014

Bcl-2(high) mantle cell lymphoma cells are sensitized to acadesine with ABT-199

Por Montraveta, Arnau, Xargay-Torrent, Sílvia, Rosich, Laia, López-Guerra, Mònica, Roldán, Jocabed, Rodríguez, Vanina, Lee-Vergés, Eriong, de Frías, Mercè, Campàs, Clara, Campo, Elias, Roué, Gaël, Colomer, Dolors
Publicado no Oncotarget (2015)

Genetic Imbalances in Progressed B-Cell Chronic Lymphocytic Leukemia and Transformed Large-Cell Lymphoma (Richter’s Syndrome)

Por Beà, Sílvia, López-Guillermo, Armando, Ribas, Maria, Puig, Xavier, Pinyol, Magda, Carrió, Ana, Zamora, Lurdes, Soler, Francesc, Bosch, Francesc, Stilgenbauer, Stephan, Colomer, Dolors, Miró, Rosa, Montserrat, Emili, Campo, Elias
Publicado em 2002

Synergistic anti-tumor activity of acadesine (AICAR) in combination with the anti-CD20 monoclonal antibody rituximab in in vivo and in vitro models of mantle cell lymphoma

Por Montraveta, Arnau, Xargay-Torrent, Sílvia, López-Guerra, Mónica, Rosich, Laia, Pérez-Galán, Patricia, Salaverria, Itziar, Beà, Silvia, Kalko, Susana G., de Frias, Mercè, Campàs, Clara, Roué, Gaël, Colomer, Dolors
Publicado em 2014

The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia

Por Xargay-Torrent, Sílvia, López-Guerra, Mónica, Rosich, Laia, Montraveta, Arnau, Roldán, Jocabed, Rodríguez, Vanina, Villamor, Neus, Aymerich, Marta, Lagisetti, Chandraiah, Webb, Thomas R., López-Otín, Carlos, Campo, Elias, Colomer, Dolors
Publicado no Oncotarget (2015)

High p27 protein levels in chronic lymphocytic leukemia are associated to low Myc and Skp2 expression, confer resistance to apoptosis and antagonize Myc effects on cell cycle

Por Caraballo, Juan M., Acosta, Juan C., Cortés, Miguel A., Albajar, Marta, Gómez-Casares, M. Teresa, Batlle-López, Ana, Cuadrado, M. Angeles, Onaindia, Arantza, Bretones, Gabriel, Llorca, Javier, Piris, Miguel A., Colomer, Dolors, León, Javier
Publicado em 2014

Early intervention during imatinib therapy in patients with newly diagnosed chronic-phase chronic myeloid leukemia: a study of the Spanish PETHEMA group

Por Cervantes, Francisco, López-Garrido, Pilar, Montero, María-Isabel, Jonte, Fermín, Martínez, Jesús, Hernández-Boluda, Juan-Carlos, Calbacho, María, Sureda, Anna, Pérez-Rus, Gloria, Nieto, José B., Pérez-López, Cristina, Román-Gómez, José, González, Marcos, Pereira, Arturo, Colomer, Dolors
Publicado em 2010

The prognostic impact of minimal residual disease in patients with chronic lymphocytic leukemia requiring first-line therapy

Por Santacruz, Rodrigo, Villamor, Neus, Aymerich, Marta, Martínez-Trillos, Alejandra, López, Cristina, Navarro, Alba, Rozman, María, Beà, Sílvia, Royo, Cristina, Cazorla, Maite, Colomer, Dolors, Giné, Eva, Pinyol, Magda, Puente, Xose S., López-Otín, Carlos, Campo, Elías, López-Guillermo, Armando, Delgado, Julio
Publicado em 2014

Non-hepatosplenic γδ T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation

Por Garcia-Herrera, Adriana, Song, Joo Y., Chuang, Shih-Sung, Villamor, Neus, Colomo, Luis, Pittaluga, Stefania, Alvaro, Tomas, Rozman, Maria, de Anda Gonzalez, Jazmin, Arrunategui, Ana Maria, Fernandez, Eva, Gonzalvo, Elena, Estrach, Teresa, Colomer, Dolors, Raffeld, Mark, Gaulard, Philippe, Campo, Elias, Jaffe, Elaine S., Martinez, Antonio
Publicado em 2011

CD69 expression potentially predicts response to bendamustine and its modulation by ibrutinib or idelalisib enhances cytotoxic effect in chronic lymphocytic leukemia

Por Montraveta, Arnau, Lee-Vergés, Eriong, Roldán, Jocabed, Jiménez, Laura, Cabezas, Sandra, Clot, Guillem, Pinyol, Magda, Xargay-Torrent, Sílvia, Rosich, Laia, Arimany-Nardí, Cristina, Aymerich, Marta, Villamor, Neus, López-Guillermo, Armando, Pérez-Galán, Patricia, Roué, Gaël, Pastor-Anglada, Marçal, Campo, Elías, López-Guerra, Mónica, Colomer, Dolors
Publicado no Oncotarget (2015)

The human CD38 monoclonal antibody daratumumab shows anti-tumor activity and hampers leukemia-microenvironment interactions in chronic lymphocytic leukemia

Por Matas-Céspedes, Alba, Vidal-Crespo, Anna, Rodriguez, Vanina, Villamor, Neus, Delgado, Julio, Giné, Eva, Roca-Ho, Heleia, Menéndez, Pablo, Campo, Elías, López-Guillermo, Armando, Colomer, Dolors, Roué, Gaël, Wiestner, Adrian, Parren, Paul W.H.I., Doshi, Parul, van Bueren, Jeroen Lammerts, Pérez-Galán, Patricia
Publicado no Clin Cancer Res (2016)

Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy

Por Barragán, Eva, Montesinos, Pau, Camos, Mireia, González, Marcos, Calasanz, Maria J., Román-Gómez, José, Gómez-Casares, Maria T., Ayala, Rosa, López, Javier, Fuster, Óscar, Colomer, Dolors, Chillón, Carmen, Larrayoz, María J., Sánchez-Godoy, Pedro, González-Campos, José, Manso, Félix, Amador, Maria L., Vellenga, Edo, Lowenberg, Bob, Sanz, Miguel A.
Publicado em 2011